Comparative expression of liver cytochrome P450-dependent monooxygenases in the horse and in other agricultural and laboratory species.
Authors: Nebbia C, Dacasto M, Rossetto Giaccherino A, Giuliano Albo A, Carletti M
Journal: Veterinary journal (London, England : 1997)
Summary
# Editorial Summary Horses metabolise xenobiotics via hepatic cytochrome P450 enzymes in patterns broadly similar to other species, yet with functionally significant differences that have direct implications for pharmaceutical safety and efficacy. Nebbia and colleagues compared the expression and catalytic activity of major P450 subfamilies (CYP 1A, 2B, 2E, and 3A) in equine liver microsomes against cattle, pigs, broiler chicks, rabbits, and rats using Western blot analysis and in vitro substrate metabolism assays. Equine liver showed notably higher CYP 1A activity (particularly for ethoxyresorufin and methoxyresorufin metabolism) but substantially lower capacity for aminopyrine and ethoxycoumarin metabolism compared with food-producing species, suggesting horses occupy a distinct position on the spectrum of P450 functionality. These quantitative differences underscore why extrapolating drug metabolism data from cattle, pigs, or laboratory models to equine patients is unreliable, and reinforce the critical importance of conducting species-specific pharmacokinetic and residue depletion studies before clinical application or prescribing decisions—particularly given the potential for unexpected drug accumulation or subtherapeutic efficacy in horses.
Read the full abstract on PubMed
Practical Takeaways
- •Drug dosing and efficacy predictions cannot be reliably extrapolated from other species to horses due to significant differences in liver enzyme activity profiles
- •Residue depletion studies and withdrawal periods must be conducted specifically in horses rather than relying on data from cattle or other food-producing animals
- •Species-specific pharmacokinetic studies are essential before clinical use of new drugs in equine practice to ensure safety and efficacy
Key Findings
- •Horses express CYP 1A, CYP 2B, CYP 2E, and CYP 3A subfamilies in liver microsomes similar to other species studied
- •Equine preparations showed the highest activity for CYP 1A substrates (ethoxyresorufin and methoxyresorufin metabolism) and lowest for aminopyrine and ethoxycoumarin
- •Large quantitative differences in substrate metabolism rates exist between minor species (rabbits, horses) and major food-producing species (cattle, pigs, broiler chicks)
- •Interspecies differences in cytochrome P450 activity are primarily quantitative rather than qualitative, except for one N-demethylation pathway in broiler chicks